184 related articles for article (PubMed ID: 32621681)
21. Breast: Sezary Syndrome: A Unique Presentation.
Bedayat A; Mirzabeigi M; Yu H; Hultman R; MacMaster S
Breast J; 2015; 21(4):423-7. PubMed ID: 25939954
[TBL] [Abstract][Full Text] [Related]
22. Bullous Sézary syndrome.
Zina G; Bernengo MG; Zina AM
Dermatologica; 1981; 163(1):25-33. PubMed ID: 7024006
[TBL] [Abstract][Full Text] [Related]
23. Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study.
Mangold AR; Thompson AK; Davis MD; Saulite I; Cozzio A; Guenova E; Hodak E; Amitay-Laish I; Pujol RM; Pittelkow MR; Gniadecki R
J Am Acad Dermatol; 2017 Oct; 77(4):719-727. PubMed ID: 28709694
[TBL] [Abstract][Full Text] [Related]
24. Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile.
Saed G; Fivenson DP; Naidu Y; Nickoloff BJ
J Invest Dermatol; 1994 Jul; 103(1):29-33. PubMed ID: 8027577
[TBL] [Abstract][Full Text] [Related]
25. Hypoglycemia in a patient with advanced Sezary syndrome.
Anagnostis P; Vakalopoulou S; Slavakis A; Simoulidou E; Rakitzi P; Garipidou V; Harsoulis F
Leuk Lymphoma; 2009 Feb; 50(2):284-6. PubMed ID: 19160123
[No Abstract] [Full Text] [Related]
26. [Atypical Sézary syndrome in a young subject].
Jabran-Maanaoui S; Chauvet P; Gillard M; Carpentier B; Pascal L; Quinchon JF; Modiano P
Ann Dermatol Venereol; 2020 May; 147(5):355-360. PubMed ID: 31806381
[TBL] [Abstract][Full Text] [Related]
27. Sarcoidal tissue reaction in Sézary syndrome.
Gregg PJ; Kantor GR; Telang GH; Lessin SR; Nowell PC; Vonderheid EC
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):372-6. PubMed ID: 10901727
[TBL] [Abstract][Full Text] [Related]
28. Brentuximab-induced splinter nail haemorrhages in a patient with Sézary syndrome: A case report.
Filipovic N; Likic R; Bulat V; Gašparov S; Delas Azdajic M
Br J Clin Pharmacol; 2022 Aug; 88(8):3883-3886. PubMed ID: 35088431
[TBL] [Abstract][Full Text] [Related]
29. Sézary syndrome-clinical and histopathologic features, differential diagnosis, and treatment.
Spicknall KE
Semin Cutan Med Surg; 2018 Mar; 37(1):18-23. PubMed ID: 29719016
[TBL] [Abstract][Full Text] [Related]
30. Sezary syndrome: a case report and a review of the molecular pathomechanism and management.
Ng PP; Goh CL
Ann Acad Med Singap; 1998 Nov; 27(6):864-7. PubMed ID: 10101566
[TBL] [Abstract][Full Text] [Related]
31. [Sézary syndrome].
Chen CC; Wang WJ; Hwang WL; Chou G
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Mar; 51(3):244-8. PubMed ID: 8490802
[TBL] [Abstract][Full Text] [Related]
32. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
33. Effect of insulin-dependent diabetes mellitus on response to extracorporeal photopheresis in patients with Sézary syndrome.
Bouwhuis SA; el-Azhary RA; Gibson LE; McEvoy MT; Pittelkow MR
J Am Acad Dermatol; 2002 Jul; 47(1):63-7. PubMed ID: 12077583
[TBL] [Abstract][Full Text] [Related]
34. [Diagnostics of primary cutaneous lymphomas].
Felcht M; Hillen U; Klemke CD
Hautarzt; 2017 Sep; 68(9):696-701. PubMed ID: 28779267
[TBL] [Abstract][Full Text] [Related]
35. [Minimal change nephropathy and IgA deposits associated with a Sezary syndrome].
Bichon A; Brue A; Godefroy R; Sallee M; Daniel L; Farnarier C; Gobin N; Abed S; Richard MA; Villani P; Malissen N; Daumas A
Rev Med Interne; 2022 Jan; 43(1):48-53. PubMed ID: 34419323
[TBL] [Abstract][Full Text] [Related]
36. [T-cell prolymphocytic leukemia: potential diagnostic pitfalls].
Dessart P; Lemaire P; Le Dû K; Sandrini J; Prophette B; Maillard H
Ann Dermatol Venereol; 2014 Dec; 141(12):777-81. PubMed ID: 25433931
[TBL] [Abstract][Full Text] [Related]
37. The emergence of Sézary cells during the treatment of cutaneous T-cell lymphoma.
Sato M; Ishikawa O; Miyachi Y
Br J Dermatol; 1995 Nov; 133(5):810-3. PubMed ID: 8555042
[TBL] [Abstract][Full Text] [Related]
38. Massive lymphomatous nail involvement in Sézary syndrome.
Tosti A; Fanti PA; Varotti C
Dermatologica; 1990; 181(2):162-4. PubMed ID: 2242787
[TBL] [Abstract][Full Text] [Related]
39. Cutaneous cryptococcosis mimicking basal cell carcinoma in a patient with Sézary syndrome.
Töröcsik D; Gergely L; Veres I; Remenyik É; Bégány Á
Acta Derm Venereol; 2012 May; 92(3):286-7. PubMed ID: 22434510
[No Abstract] [Full Text] [Related]
40. Expression of CD164 on Malignant T cells in Sézary Syndrome.
Guenova E; Ignatova D; Chang YT; Contassot E; Mehra T; Saulite I; Navarini AA; Mitev V; Dummer R; Kazakov DV; French LE; Hoetzenecker W; Cozzio A
Acta Derm Venereol; 2016 May; 96(4):464-7. PubMed ID: 26524186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
